Modi WS, Dean M, Seuanez HN, Mukaida N, Matsushima K, O'Brien SJ (January 1990). “Monocyte-derived neutrophil chemotactic factor (MDNCF/IL-8) resides in a gene cluster along with several other members of the platelet factor 4 gene superfamily”. 《Human Genetics》84 (2): 185–187. doi:10.1007/BF00208938. PMID1967588. S2CID2217894.
Köhidai L, Csaba G (July 1998). “Chemotaxis and chemotactic selection induced with cytokines (IL-8, RANTES and TNF-alpha) in the unicellular Tetrahymena pyriformis”. 《Cytokine》10 (7): 481–486. doi:10.1006/cyto.1997.0328. PMID9702410. S2CID33755476.
Vlahopoulos S, Boldogh I, Casola A, Brasier AR (September 1999). “Nuclear factor-kappaB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation”. 《Blood》94 (6): 1878–1889. doi:10.1182/blood.V94.6.1878.418k03_1878_1889. PMID10477716. S2CID25974629.
Sharabiani MT, Vermeulen R, Scoccianti C, Hosnijeh FS, Minelli L, Sacerdote C, Palli D, Krogh V, Tumino R, Chiodini P, Panico S, Vineis P (May 2011). “Immunologic profile of excessive body weight”. 《Biomarkers》16 (3): 243–251. doi:10.3109/1354750X.2010.547948. PMID21506696. S2CID36127785.
Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, Christmas SE (January 2000). “Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro”. 《Cytokine》12 (1): 78–85. doi:10.1006/cyto.1999.0518. PMID10623446.
Itoh Y, Joh T, Tanida S, Sasaki M, Kataoka H, Itoh K, Oshima T, Ogasawara N, Togawa S, Wada T, Kubota H, Mori Y, Ohara H, Nomura T, Higashiyama S, Itoh M (March 2005). “IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells”. 《Cytokine》29 (6): 275–282. doi:10.1016/j.cyto.2004.11.005. PMID15749028.
Brown AS, Hooton J, Schaefer CA, Zhang H, Petkova E, Babulas V, Perrin M, Gorman JM, Susser ES (May 2004). “Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring”. 《The American Journal of Psychiatry》161 (5): 889–895. doi:10.1176/appi.ajp.161.5.889. PMID15121655.
Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC (July 2004). “Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia”. 《The Journal of Clinical Psychiatry》65 (7): 940–947. doi:10.4088/JCP.v65n0710. PMID15291683.
Reeves EP, Williamson M, O'Neill SJ, Greally P, McElvaney NG (June 2011). “Nebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosis”. 《American Journal of Respiratory and Critical Care Medicine》183 (11): 1517–1523. doi:10.1164/rccm.201101-0072oc. PMID21330456.
Hoffmann K, Xifró RA, Hartweg JL, Spitzlei P, Meis K, Molderings GJ, von Kügelgen I (January 2013). “Inhibitory effects of benzodiazepines on the adenosine A(2B) receptor mediated secretion of interleukin-8 in human mast cells”. 《European Journal of Pharmacology》700 (1–3): 152–158. doi:10.1016/j.ejphar.2012.12.003. PMID23266380.
Bacon K, Baggiolini M, Broxmeyer H, Horuk R, Lindley I, Mantovani A, Maysushima K, Murphy P, Nomiyama H, Oppenheim J, Rot A, Schall T, Tsang M, Thorpe R, Van Damme J, Wadhwa M, Yoshie O, Zlotnik A, Zoon K (October 2002). “Chemokine/chemokine receptor nomenclature”. 《Journal of Interferon & Cytokine Research》22 (10): 1067–1068. doi:10.1089/107999002760624305. PMID12433287.
doi.org
Milosevic, V. et al. Wnt/IL-1β/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5.Int. J. Cancer, https://doi.org/10.1002/ijc.32419
Modi WS, Dean M, Seuanez HN, Mukaida N, Matsushima K, O'Brien SJ (January 1990). “Monocyte-derived neutrophil chemotactic factor (MDNCF/IL-8) resides in a gene cluster along with several other members of the platelet factor 4 gene superfamily”. 《Human Genetics》84 (2): 185–187. doi:10.1007/BF00208938. PMID1967588. S2CID2217894.
Köhidai L, Csaba G (July 1998). “Chemotaxis and chemotactic selection induced with cytokines (IL-8, RANTES and TNF-alpha) in the unicellular Tetrahymena pyriformis”. 《Cytokine》10 (7): 481–486. doi:10.1006/cyto.1997.0328. PMID9702410. S2CID33755476.
Vlahopoulos S, Boldogh I, Casola A, Brasier AR (September 1999). “Nuclear factor-kappaB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation”. 《Blood》94 (6): 1878–1889. doi:10.1182/blood.V94.6.1878.418k03_1878_1889. PMID10477716. S2CID25974629.
Sharabiani MT, Vermeulen R, Scoccianti C, Hosnijeh FS, Minelli L, Sacerdote C, Palli D, Krogh V, Tumino R, Chiodini P, Panico S, Vineis P (May 2011). “Immunologic profile of excessive body weight”. 《Biomarkers》16 (3): 243–251. doi:10.3109/1354750X.2010.547948. PMID21506696. S2CID36127785.
Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, Christmas SE (January 2000). “Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro”. 《Cytokine》12 (1): 78–85. doi:10.1006/cyto.1999.0518. PMID10623446.
Itoh Y, Joh T, Tanida S, Sasaki M, Kataoka H, Itoh K, Oshima T, Ogasawara N, Togawa S, Wada T, Kubota H, Mori Y, Ohara H, Nomura T, Higashiyama S, Itoh M (March 2005). “IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells”. 《Cytokine》29 (6): 275–282. doi:10.1016/j.cyto.2004.11.005. PMID15749028.
Brown AS, Hooton J, Schaefer CA, Zhang H, Petkova E, Babulas V, Perrin M, Gorman JM, Susser ES (May 2004). “Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring”. 《The American Journal of Psychiatry》161 (5): 889–895. doi:10.1176/appi.ajp.161.5.889. PMID15121655.
Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC (July 2004). “Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia”. 《The Journal of Clinical Psychiatry》65 (7): 940–947. doi:10.4088/JCP.v65n0710. PMID15291683.
Reeves EP, Williamson M, O'Neill SJ, Greally P, McElvaney NG (June 2011). “Nebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosis”. 《American Journal of Respiratory and Critical Care Medicine》183 (11): 1517–1523. doi:10.1164/rccm.201101-0072oc. PMID21330456.
Hoffmann K, Xifró RA, Hartweg JL, Spitzlei P, Meis K, Molderings GJ, von Kügelgen I (January 2013). “Inhibitory effects of benzodiazepines on the adenosine A(2B) receptor mediated secretion of interleukin-8 in human mast cells”. 《European Journal of Pharmacology》700 (1–3): 152–158. doi:10.1016/j.ejphar.2012.12.003. PMID23266380.
Bacon K, Baggiolini M, Broxmeyer H, Horuk R, Lindley I, Mantovani A, Maysushima K, Murphy P, Nomiyama H, Oppenheim J, Rot A, Schall T, Tsang M, Thorpe R, Van Damme J, Wadhwa M, Yoshie O, Zlotnik A, Zoon K (October 2002). “Chemokine/chemokine receptor nomenclature”. 《Journal of Interferon & Cytokine Research》22 (10): 1067–1068. doi:10.1089/107999002760624305. PMID12433287.
Modi WS, Dean M, Seuanez HN, Mukaida N, Matsushima K, O'Brien SJ (January 1990). “Monocyte-derived neutrophil chemotactic factor (MDNCF/IL-8) resides in a gene cluster along with several other members of the platelet factor 4 gene superfamily”. 《Human Genetics》84 (2): 185–187. doi:10.1007/BF00208938. PMID1967588. S2CID2217894.
Köhidai L, Csaba G (July 1998). “Chemotaxis and chemotactic selection induced with cytokines (IL-8, RANTES and TNF-alpha) in the unicellular Tetrahymena pyriformis”. 《Cytokine》10 (7): 481–486. doi:10.1006/cyto.1997.0328. PMID9702410. S2CID33755476.
Vlahopoulos S, Boldogh I, Casola A, Brasier AR (September 1999). “Nuclear factor-kappaB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation”. 《Blood》94 (6): 1878–1889. doi:10.1182/blood.V94.6.1878.418k03_1878_1889. PMID10477716. S2CID25974629.
Sharabiani MT, Vermeulen R, Scoccianti C, Hosnijeh FS, Minelli L, Sacerdote C, Palli D, Krogh V, Tumino R, Chiodini P, Panico S, Vineis P (May 2011). “Immunologic profile of excessive body weight”. 《Biomarkers》16 (3): 243–251. doi:10.3109/1354750X.2010.547948. PMID21506696. S2CID36127785.